Last edition
News about Manufacturing
Snapdragon Chemistry Expands Massachusetts Facility to Support Peptide Projects
Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts, by adding a new GMP manufacturing suite to strengthen the development and manufacturing of peptide therapies.
Manufacturing | 25/08/2025 | By Dineshwori | 229
Johnson and Johnson Commits USD 2 Billion to Expand US Manufacturing Amid Tariff Pressures
Johnson and Johnson has announced it will invest USD 2 billion in expanding its US manufacturing capacity over the next decade, responding to escalating concerns over trade and potential drug import tariffs.
Manufacturing | 22/08/2025 | By Darshana | 145
Jazz and Saniona Enter Global License Deal for Preclinical Epilepsy Candidate SAN2355
Jazz Pharmaceuticals and Saniona have entered into a global licensing agreement, giving Jazz exclusive worldwide rights to develop and commercialise SAN2355, a highly selective Kv7.2/Kv7.3 activator currently in preclinical development for epilepsy and other neurological conditions. <br />
Manufacturing | 21/08/2025 | By Dineshwori | 235
Piramal Pharma, NewAmsterdam Launch Dedicated OSD Suite at Sellersville Site in US
Piramal Pharma Solutions and NewAmsterdam Pharma have inaugurated a dedicated oral solid dosage (OSD) suite at Piramal’s Sellersville, Pennsylvania facility to support the production of NewAmsterdam’s investigational fixed-dose combination cholesterol therapy.
Manufacturing | 21/08/2025 | By Mrinmoy Dey | 259
Welcure Drugs to Invest INR 70 Crore in New Agro-Pharma Research Lab
Welcure Drugs and Pharmaceuticals has announced its plan to establish an agro-pharma research laboratory with an investment of INR 70-80 crore.
Manufacturing | 21/08/2025 | By Dineshwori | 382
PLI Scheme Transforms India from Net Importer to Net Exporter of Bulk Drugs in Just Three Years
The PLI scheme has helped India shift from being a net importer of bulk drugs (– INR 1,930 crore in FY 2021-22) to a net exporter (INR 2,280 crore), while significantly reducing the gap between domestic manufacturing capacity and the demand for critical drugs.
Manufacturing | 20/08/2025 | By Dineshwori | 546
Orbia's New Whitepaper Charts Regulatory Path to Low-GWP Propellant Manufacturing for pMDIs
Orbia Fluor and Energy Materials has published a new whitepaper, produced in collaboration with DLRC Group, that offers vital regulatory guidance to support the pharmaceutical industry's transition to low-global warming potential (low-GWP) propellants in pressurised metered dose inhalers (pMDIs).
Manufacturing | 19/08/2025 | By Darshana | 135
WuXi Biologics, a leading global contract research, development and manufacturing organisation (CRDMO), has announced that its Dundalk, Ireland facility has been approved by the European Medicines Agency (EMA) as a commercial manufacturing site for a client’s innovative biologic.
Manufacturing | 18/08/2025 | By Dineshwori | 259
Zydus Lifesciences' Ahmedabad Manufacturing Plant Clears US FDA Inspection with Zero Observations
The inspection, which took place from 11 to 13 August 2025, evaluated three products under general current Good Manufacturing Practice (cGMP) standards and concluded without any regulatory findings or compliance issues.
Manufacturing | 18/08/2025 | By Darshana | 515
AbbVie to Invest USD 195 Million to Expand API Manufacturing in US
AbbVie will invest USD 195 million to expand active pharmaceutical ingredient manufacturing at its North Chicago plant, strengthening US production capacity for current and next-generation medicines.
Manufacturing | 13/08/2025 | By Mrinmoy Dey | 145
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy